Seelos Therapeutics Inc (SEEL)

[SocialBoom]

Thanks Eman...

Good information and I think we can now make some assumptions on Femprox. Well,,, I can make some assumptions on Femprox.

Femprox is dead. At least for the next year or 5. These guys were not able to get a deal and at the core the problem is a lack of interest by the partners. The lack of interest is only explainable in 2 ways. Either they didn't feel that there was enough market share for their time and money or they had doubts about Femprox's overall effectiveness and chances at eventually gaining approval, which is what I think.

Things could certainly change I guess, but this explains why the management team fails to mention Femprox in the letter to shareholders and has basically tried to walk back any promotion of that as a pipeline candidate.

So now we must face the future with this outlook. We are 100% dependent on Vitaros to generate cash while we wait for 2017-18 at the earliest for RayVa.

I don't see this as a good situation. The management team must find a way to accumulate additional revenue or cut costs or we can look forward to every dollar of the Aspire deal hitting the market.

I suppose they might be able to out license RayVa in Europe, or gain some additional license revenue for Vitaros in Asia and South America.

So we are really starring down the barrel of Vitaros. The weight of importance of market share in Europe is now bigger than ever.

Let's hope

PS... It's time to lay off Neil Morton, and reevaluate the size of the BODs.